Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India.
Mehendale S, Sahay S, Thakar M, Sahasrabuddhe S, Kakade M, Shete A, Shrotri A, Spentzou A, Tarragona T, Stevens G, Kochhar S, Excler JL, Fast P, Paranjape R.
Mehendale S, et al. Among authors: paranjape r.
Indian J Med Res. 2010 Aug;132:168-75.
Indian J Med Res. 2010.
PMID: 20716817
Free article.
Clinical Trial.